{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:43:25Z","timestamp":1761738205165,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,28]]},"DOI":"10.7759\/cureus.95633","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:01:59Z","timestamp":1761714119000},"source":"Crossref","is-referenced-by-count":0,"title":["Chronic Myeloid Leukemia Harboring a Novel Four-Way Variant Translocation t(7;22;9;15)(p15;q11.2;q34.1;q22) With Cryptic Double Philadelphia Chromosomes"],"prefix":"10.7759","author":[{"given":"Shogo","family":"Kamigaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren R","year":"2005","unstructured":"Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005, 5:172-83. 10.1038\/nrc1567","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0220","article-title":"Chronic myeloid leukemia: a review","volume":"333","author":"Jabbour E","year":"2025","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: a review. JAMA. 2025, 333:1618-29. 10.1001\/jama.2025.0220","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-328294","article-title":"Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis","volume":"117","author":"Marzocchi G","year":"2011","unstructured":"Marzocchi G, Castagnetti F, Luatti S, et al.. Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood. 2011, 117:6793-800. 10.1182\/blood-2011-01-328294","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14030303","article-title":"Novel four-way variant translocation, t(1;9;22;16)(q21;q34;q11.2;q24), in a patient with chronic myeloid leukemia","volume":"14","author":"Son HJ","year":"2024","unstructured":"Son HJ, Lee JH. Novel four-way variant translocation, t(1;9;22;16)(q21;q34;q11.2;q24), in a patient with chronic myeloid leukemia. Diagnostics (Basel). 2024, 14:303. 10.3390\/diagnostics14030303","journal-title":"Diagnostics (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13522","article-title":"Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation","volume":"18","author":"Shetty D","year":"2022","unstructured":"Shetty D, Talker E, Jain H, et al.. Evaluation of cytogenetic response in CML patients with variant Philadelphia translocation. Asia Pac J Clin Oncol. 2022, 18:99-108. 10.1111\/ajco.13522","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-373902","article-title":"Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV","volume":"118","author":"Fabarius A","year":"2011","unstructured":"Fabarius A, Leitner A, Hochhaus A, et al.. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood. 2011, 118:6760-8. 10.1182\/blood-2011-08-373902","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4111","article-title":"The biology of CML blast crisis","volume":"103","author":"Calabretta B","year":"2004","unstructured":"Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004, 103:4010-22. 10.1182\/blood-2003-12-4111","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0777","article-title":"The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML","volume":"100","author":"O'Dwyer ME","year":"2002","unstructured":"O'Dwyer ME, Mauro MJ, Kurilik G, et al.. The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML. Blood. 2002, 100:1628-33. 10.1182\/blood-2002-03-0777","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000538512","article-title":"ISCN 2024: an international system for human cytogenomic nomenclature","volume":"164","author":"Hastings RJ","year":"2024","unstructured":"Hastings RJ, Moore S, Chia N. ISCN 2024: an international system for human cytogenomic nomenclature. Cytogenet Genome Res. 2024, 164:1-224. 10.1159\/000538512","journal-title":"Cytogenet Genome Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0776-2","article-title":"European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia","volume":"34","author":"Hochhaus A","year":"2020","unstructured":"Hochhaus A, Baccarani M, Silver RT, et al.. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. Leukemia. 2020, 34:966-84. 10.1038\/s41375-020-0776-2","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32504","article-title":"Long-term follow-up of lower dose dasatinib (50\u00a0mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia","volume":"126","author":"Naqvi K","year":"2020","unstructured":"Naqvi K, Jabbour E, Skinner J, et al.. Long-term follow-up of lower dose dasatinib (50\u00a0mg daily) as frontline therapy in newly diagnosed chronic-phase chronic myeloid leukemia. Cancer. 2020, 126:67-75. 10.1002\/cncr.32504","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2005.11.008","article-title":"A Ph-negative chronic myeloid leukemia with a complex BCR\/ABL rearrangement and a t(6;9)(p21;q34.1)","volume":"166","author":"Todori\u0107-Zivanovi\u0107 B","year":"2006","unstructured":"Todori\u0107-Zivanovi\u0107 B, Marisavljevi\u0107 D, Surace C, et al.. A Ph-negative chronic myeloid leukemia with a complex BCR\/ABL rearrangement and a t(6;9)(p21;q34.1). Cancer Genet Cytogenet. 2006, 166:180-5. 10.1016\/j.cancergencyto.2005.11.008","journal-title":"Cancer Genet Cytogenet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/319503","article-title":"Limitations of chromosome classification by multicolor karyotyping","volume":"68","author":"Lee C","year":"2001","unstructured":"Lee C, Gisselsson D, Jin C, et al.. Limitations of chromosome classification by multicolor karyotyping. Am J Hum Genet. 2001, 68:1043-7. 10.1086\/319503","journal-title":"Am J Hum Genet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8166-5-3","article-title":"Spectral Karyotyping for identification of constitutional chromosomal abnormalities at a national reference laboratory","volume":"5","author":"Anguiano A","year":"2012","unstructured":"Anguiano A, Wang BT, Wang SR, et al.. Spectral Karyotyping for identification of constitutional chromosomal abnormalities at a national reference laboratory. Mol Cytogenet. 2012, 5:3. 10.1186\/1755-8166-5-3","journal-title":"Mol Cytogenet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2012.1037","article-title":"A novel cytogenetic abnormality t(7;8)(p11.2:q11.2) and a four-way Philadelphia translocation in an imatinib mesylate-resistant chronic myeloid leukemia patient","volume":"5","author":"Al-Achkar W","year":"2013","unstructured":"Al-Achkar W, Aljapawe A, Almedani S, Liehr T, Wafa A. A novel cytogenetic abnormality t(7;8)(p11.2:q11.2) and a four-way Philadelphia translocation in an imatinib mesylate-resistant chronic myeloid leukemia patient. Oncol Lett. 2013, 5:617-20. 10.3892\/ol.2012.1037","journal-title":"Oncol Lett"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.7866","article-title":"Co-existence of isodicentric Ph chromosomes and the three-way Ph chromosome variant t(3;9;22)(p21;q34;q11) in a rare case of chronic myeloid leukemia","volume":"15","author":"Li Q","year":"2018","unstructured":"Li Q, Lin XJ, Chen H, Gong J, Li Z, Chen XN. Co-existence of isodicentric Ph chromosomes and the three-way Ph chromosome variant t(3;9;22)(p21;q34;q11) in a rare case of chronic myeloid leukemia. Oncol Lett. 2018, 15:4599-603. 10.3892\/ol.2018.7866","journal-title":"Oncol Lett"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.lrr.2013.07.004","article-title":"Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy","volume":"2","author":"Aliano S","year":"2013","unstructured":"Aliano S, Cirmena G, Fugazza G, Bruzzone R, Palermo C, Sessarego M. Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy. Leuk Res Rep. 2013, 2:75-8. 10.1016\/j.lrr.2013.07.004","journal-title":"Leuk Res Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.16711","article-title":"A three way complex translocation (4; 9; 22) in two patients with chronic myelocytic leukemia","volume":"1","author":"Sheth FJ","year":"2005","unstructured":"Sheth FJ, Sheth JJ, Verhest A. A three way complex translocation (4; 9; 22) in two patients with chronic myelocytic leukemia. J Cancer Res Ther. 2005, 1:108-10. 10.4103\/0973-1482.16711","journal-title":"J Cancer Res Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/377800-chronic-myeloid-leukemia-harboring-a-novel-four-way-variant-translocation-t722915p15q112q341q22-with-cryptic-double-philadelphia-chromosomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:02:01Z","timestamp":1761714121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/377800-chronic-myeloid-leukemia-harboring-a-novel-four-way-variant-translocation-t722915p15q112q341q22-with-cryptic-double-philadelphia-chromosomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.95633","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}